Two observers of Israeli technology can paint starkly different pictures of the sector's health, each drawing defensible conclusions from the available data. One points to a capital winter marked by venture fundraising at decade lows, deal scarcity, and the weight of ongoing conflict. The other counters that 2025 brought a rebound - the strongest year since the boom.
Both accounts withstand examination because they draw from different metrics. Venture fund fundraising has indeed collapsed, sitting 68% below its peak according to IVC Research Center data, a steeper decline than America's. Yet the opposing view finds support in capital flowing into Israeli companies from global sources. Equity invested in private Israeli companies reached roughly half the 2021 peak in 2025, excluding public listings and lending. Deal frequency has declined annually since 2021, with artificial intelligence and cybersecurity commanding two of every three invested dollars.
Three patterns in the data offer insight into the market's trajectory. First, the investing divisions of major technology companies - NVIDIA, Google, Intel and others - have shifted their Israeli investment strategy. For the first time in a decade of IVC tracking, the majority of their Israeli investments in 2025 went to seed and Series A companies rather than mature, later-stage enterprises favored in previous years. Corporations are typically the acquirers of Israeli tech exits, and they do not fund the earliest companies without purpose; they do so when identifying targets for five- to ten-year investment horizons.
Second, while concentration in two sectors appears fragile, it represents open space. Startup formation has remained relatively stable through major disruptions, with founders continuing to build beyond AI and cybersecurity. Life sciences, industrial technologies, and quantum and robotics teams draw from deep educational and defense sector traditions.
Third, financing rounds have grown scarcer while typical round sizes have roughly doubled since the peak. Rather than writing fewer and smaller checks, investors are concentrating capital behind their strongest convictions. The portfolio is consolidating around strength rather than thinning randomly.
The advantages in this environment - diminished competition, strategic validation at early stages, and capital concentrating behind leading companies - favor investors positioned during the period when broader consensus remains cautious.